Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Drug Development Consulting Holding ApS
APS
Active
Advertising protection
CVR 42285722
Smedeland 36, 2600
Glostrup
Activities of holding companies
·
NACE 6421
Est. 2021 · 5 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Drug Development Consulting Holding ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
CG
Coöperatieve Gilde Healthcare Services III U.A.
Founder
Founder
2021
RH
René Holmen Pedersen
Management
Management
2023
Former (3)
JM
Jasper Michiel van Gorp
Management
Management
2021 – 2021
RK
Rasmus Koch Nelund
Management
Management
2023 – 2025
AM
Alejandra Maria Cristina Bonifacini Mørk
Management
Management
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
RN
Rafael Natanek
Board of Directors
Board of Directors
2023
NP
Niels Peder Nielsen
Chairman
Chairman
2023
AM
Alejandra Maria Cristina Bonifacini Mørk
Board of Directors
Board of Directors
2022
RK
Redmar Koene
Board of Directors
Board of Directors
2021
Former (1)
MK
Mette Kirstine Agger
Board of Directors
Board of Directors
2021 – 2024
Shareholders
As of last annual report
GHS III Midco B.V. — 66.67–89.99%
DDC Mørk Holding ApS — 15–19.99%
Coöperatieve Gilde Healthcare Services III U.A. — 66.67–89.99%
MØRK HOLDING 2007 ApS — 25–33.32%
100%
Shareholder
Type
Ownership
Votes
Since
GHS III Midco B.V.
Company
66.67–89.99%
66.67–89.99%
2024
DDC Mørk Holding ApS
Company
15–19.99%
15–19.99%
2022
Coöperatieve Gilde Healthcare Services III U.A.
Individual
66.67–89.99%
66.67–89.99%
2022
MØRK HOLDING 2007 ApS
Company
25–33.32%
25–33.32%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Drug Development Consulting Holding ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
2021 – 2023